(R)-2-((R)-3-Amino-3-(4-((2-(2-methoxyethyl)quinolin-4-yl)methoxy)phenyl)-2-oxopyrrolidin-1-yl)-Nhydroxy-4-methylpentanamide

ID: ALA3221864

PubChem CID: 86291010

Max Phase: Preclinical

Molecular Formula: C29H36N4O5

Molecular Weight: 520.63

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCCc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C29H36N4O5/c1-19(2)16-26(27(34)32-36)33-14-13-29(30,28(33)35)21-8-10-23(11-9-21)38-18-20-17-22(12-15-37-3)31-25-7-5-4-6-24(20)25/h4-11,17,19,26,36H,12-16,18,30H2,1-3H3,(H,32,34)/t26-,29-/m1/s1

Standard InChI Key:  OKHKINWJYOOKOF-GGXMVOPNSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   12.2889   -5.7718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6992   -5.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5060   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5935   -6.0494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8409   -6.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3627   -4.3022    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3310   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7455   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5705   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9810   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5705   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7455   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8102   -5.2290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2206   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6956   -5.9418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -6.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -6.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0456   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0456   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -3.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -3.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6956   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1725   -6.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4684   -5.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9455   -5.2168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1307   -5.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8348   -6.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6120   -4.7011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3452   -6.7607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7004   -7.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4011   -8.0616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7046   -7.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2861   -8.1056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7054   -8.8307    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2869   -9.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5935   -4.4087    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  2  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 15 24  1  0
 19 24  1  0
 14 18  1  0
 10 13  1  0
  3  7  1  0
 25 26  1  0
 26 27  1  1
 27 28  1  0
 28 29  1  0
 28 30  1  0
  1 26  1  0
 25 31  2  0
 25 32  1  0
 32 33  1  0
 16 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
  3 38  1  1
M  END

Associated Targets(Human)

Whole blood (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM10 Tchem ADAM10 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP7 Tchem Matrix metalloproteinase 7 (1073 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP13 Tchem Matrix metalloproteinase 13 (4133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP14 Tchem Matrix metalloproteinase 14 (1592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.63Molecular Weight (Monoisotopic): 520.2686AlogP: 3.31#Rotatable Bonds: 11
Polar Surface Area: 127.01Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.74CX Basic pKa: 7.46CX LogP: 2.62CX LogD: 2.44
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.37

References

1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P.  (2011)  Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors,  (10): [10.1039/C0MD00261E]

Source